In the latest episode, we interviewed Caroline Fox, MD, MPH, the Senior Vice President of Genetics and Target Discovery at a Flagship Pioneering start-up company. There, she leads a group applying a novel method of genomics to identify drug targets. Prior to that, she was Vice President and Head of Genome and Biomarker Sciences at Merck Research Labs (MRL), where she lead a group of nearly 150 scientists to leverage genetics and biomarker science to drive drug discovery and development across the R&D pipeline.